Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Wolfgang Andreas Weber

Department Chair

Technical University of Munich

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Medical Imaging Medical Imaging professors in Germany

Articles (20)

Year:

2026

Year:

2026

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (12)

Christoph Knappich

Technical University of Munich

GERMANY

View details

Matthias Trenner

Technical University of Munich

GERMANY

View details

Robert Tauber

Klinikum rechts der Isar der Technischen Universität München

GERMANY

View details

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Timothy Witney

King’s College London

UNITED KINGDOM

View details

Katja Steiger

Ludwig-Maximilians-Universität München

GERMANY

View details

Susanne Kossatz

Assistant Professor

Klinikum rechts der Isar der Technischen Universität München

GERMANY

View details

Eva M Fallenberg

Professor of Radiology

Technical University of Munich

GERMANY

View details

Twan Lammers

Professor

GERMANY

View details

David Manuel Kersting

Universität Duisburg-Essen

GERMANY

View details

Malene G. Hildebrandt

Clinical professor

University of Southern Denmark

DENMARK

View details

John Ronald

Scientist, Associate Professor

Western University

CANADA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Wolfgang Andreas Weber

Research Interests

Make your next move.

Explore related searches

Articles (20)

Imaging the hallmarks of cancer

Targeted Radionuclide Therapy: Current Landscape and Combination Approaches to Improve Oncology Outcomes

Combining [177Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer

Theranostics - a sure cure for cancer after 100 years?

Aortic Vascular Graft and Endograft Infection–Patient Outcome Cannot Be Determined Based on Pre-Operative Characteristics

Imaging of Cardiac Fibrosis: How Far Have We Moved From Extracellular to Cellular?

Imaging with [<sup>89</sup>Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: a phase 1/2, first-in-human trial.

Amino acid PET vs. RANO MRI for prediction of overall survival in patients with recurrent high grade glioma under bevacizumab therapy

Detecting Metastatic Patterns of Oligometastatic Breast Cancer: A Comparative Analysis of 18F-FDG PET/CT and Conventional CT Imaging

Efficiency of succinylated gelatin and amino acid infusions for kidney uptake reduction of radiolabeled αvβ6-integrin targeting peptides: considerations on clinical safety profiles

Long-Term Nephrotoxicity of <SUP>177</SUP>Lu-PSMA Radioligand Therapy

Preclinical comparison of [<SUP>177</SUP>Lu]Lu-rhPSMA-10.1 and [<SUP>177</SUP>Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies

Safety and Efficacy of Extended Therapy with [177Lu]Lu-PSMA: A German Multicenter Study

Sino-German symposium on total-body PET/CT in theranostics

Cost-effectiveness of 2-[18F]FDG-PET/CT versus CE-CT for response monitoring in patients with metastatic breast cancer

Comparative Analysis of Morphological and Functional Effects of 225Ac- and 177Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands

177Lu-PSMA-I&T for Treatment of Metastatic Castration-Resistant Prostate Cancer: Prognostic Value of Scintigraphic and Clinical Biomarkers

A Phase 1, Open-label, Dose-Ascending Study to Evaluate the Safety and Tolerability of the Therapeutic Radiopharmaceutical <SUP>131</SUP>I-MIP-1095 for the Treatment of Metastatic Castration-Resistant Prostate Cancer

A VISION Substudy of Reader Agreement on 68Ga-PSMA-11 PET/CT Scan Interpretation to Determine Patient Eligibility for 177Lu-PSMA-617 Radioligand Therapy

Adoption of Lutetium-<SUP>177</SUP> PSMA radioligand therapy for metastatic castration resistant prostate cancer: a total population analysis in Germany from 2016 to 2020

Collaborators (12)

Christoph Knappich

Matthias Trenner

Robert Tauber

Annette Raskov Kodahl

Timothy Witney

Katja Steiger

Susanne Kossatz

Eva M Fallenberg

Twan Lammers

David Manuel Kersting

Malene G. Hildebrandt

John Ronald

Make your next move.